Hydreight Announces Closing of its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise of Over-Allotment Option
Hydreight Technologies (OTC: HYDTF), a nationwide digital healthcare solutions provider, has successfully closed its oversubscribed private placement of unsecured convertible debentures, raising C$11.5 million including the full exercise of the over-allotment option.
The debentures, issued at C$1,000 each, will mature on September 4, 2028, carrying a 9.0% annual interest rate. They are convertible into common shares at C$4.06 per share, with interest payable semi-annually. The company maintains a forced conversion right if the stock trades above C$5.08 for 20 consecutive trading days.
CEO Shane Madden highlighted the company's recent achievement of profitability in Q2 and plans to use the proceeds for general corporate and working capital purposes to accelerate growth.
Hydreight Technologies (OTC: HYDTF), fornitore nazionale di soluzioni digitali per la sanità, ha chiuso con successo una collocazione privata sovrasottoscritta di debentures convertibili non garantite per C$11,5 milioni, inclusa l'esercitazione integrale dell'opzione di sovrallocazione.
Le debentures, emesse a C$1.000 ciascuna, scadranno il 4 settembre 2028 e prevedono un tasso d'interesse annuo del 9,0%. Sono convertibili in azioni ordinarie a C$4,06 per azione, con interessi pagabili semestralmente. La società si riserva il diritto di conversione forzata se il titolo quota oltre C$5,08 per 20 giorni di contrattazione consecutivi.
Il CEO Shane Madden ha sottolineato il raggiungimento della redditività nel secondo trimestre e ha dichiarato che i proventi saranno utilizzati per scopi aziendali generali e capitale circolante per accelerare la crescita.
Hydreight Technologies (OTC: HYDTF), proveedor nacional de soluciones sanitarias digitales, ha cerrado con éxito una colocación privada sobresuscrita de bonos convertibles no garantizados por C$11,5 millones, incluyendo el ejercicio completo de la opción de sobreasignación.
Los bonos, emitidos a C$1.000 cada uno, vencerán el 4 de septiembre de 2028 y devengarán un interés anual del 9,0%. Son convertibles en acciones ordinarias a C$4,06 por acción, con intereses pagaderos semestralmente. La compañía mantiene el derecho a conversión forzosa si la acción cotiza por encima de C$5,08 durante 20 días de negociación consecutivos.
El CEO Shane Madden destacó que la empresa alcanzó la rentabilidad en el segundo trimestre y que los fondos se destinarán a fines corporativos generales y capital de trabajo para acelerar el crecimiento.
Hydreight Technologies (OTC: HYDTF)는 전국 디지털 헬스케어 솔루션 제공업체로서 무담보 전환사채(컨버터블) 1,150만 캐나다달러의 초과청약된 사모발행을 전체 초과배정옵션 행사까지 포함해 성공적으로 마감했습니다.
사채는 각 C$1,000에 발행되며 만기는 2028년 9월 4일, 연 9.0% 이자율을 적용합니다. 사채는 주당 C$4.06에 보통주로 전환 가능하며 이자는 반기 단위로 지급됩니다. 주가가 C$5.08을 20거래일 연속 초과하면 회사는 강제전환권을 행사할 수 있습니다.
CEO 셰인 매든은 2분기 흑자전환 달성을 강조하며, 자금은 일반 법인 목적 및 운전자본으로 사용해 성장을 가속화할 예정이라고 밝혔습니다.
Hydreight Technologies (OTC: HYDTF), fournisseur national de solutions de santé numériques, a clôturé avec succès son placement privé sursouscrit de obligations convertibles non garanties pour C$11,5 millions, incluant l'exercice intégral de l'option de surallocation.
Les obligations, émises à C$1 000 chacune, arriveront à échéance le 4 septembre 2028 et portent un taux d'intérêt annuel de 9,0%. Elles sont convertibles en actions ordinaires à C$4,06 par action, les intérêts étant payables semi-annuellement. La société conserve un droit de conversion forcée si l'action se négocie au-dessus de C$5,08 pendant 20 jours de bourse consécutifs.
Le PDG Shane Madden a souligné que l'entreprise est devenue rentable au deuxième trimestre et a déclaré que les fonds seraient utilisés à des fins générales d'entreprise et pour le fonds de roulement afin d'accélérer la croissance.
Hydreight Technologies (OTC: HYDTF), ein landesweiter Anbieter digitaler Gesundheitslösungen, hat eine überzeichnete Privatplatzierung von erfolgreich abgeschlossen, einschließlich vollständiger Ausübung der Mehrzuteilungsoption.
Die Schuldverschreibungen, ausgegeben zu C$1.000 je Stück, laufen am 4. September 2028 aus und tragen einen jährlichen Zinssatz von 9,0%. Sie sind in Stammaktien zu C$4,06 pro Aktie wandelbar; die Zinszahlungen erfolgen halbjährlich. Das Unternehmen behält sich ein Zwangswandlungsrecht vor, falls die Aktie für 20 aufeinanderfolgende Handelstage über C$5,08 notiert.
CEO Shane Madden hob hervor, dass das Unternehmen im zweiten Quartal profitabel geworden sei, und erklärte, die Mittel für allgemeine Unternehmenszwecke und das Betriebskapital zur Beschleunigung des Wachstums einsetzen zu wollen.
- Successfully raised C$11.5M through oversubscribed convertible debenture offering
- Company achieved profitability in Q2 2025
- Full exercise of over-allotment option indicates strong investor demand
- Favorable conversion terms with 9.0% annual interest rate
- Additional debt obligation with C$11.5M in convertible debentures
- Potential future dilution for existing shareholders upon conversion
- High interest rate of 9.0% increases debt servicing costs
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in nationwide digital healthcare solutions, is pleased to announce that it has closed its previously announced private placement of unsecured convertible debentures (the “Offering”). Canaccord Genuity Corp. acted as lead agent and sole bookrunner, for and on behalf of a syndicate of agents which included Beacon Securities Ltd. (collectively the “Agents”), in connection with the private placement, pursuant to which the Company issued an aggregate of 11,500 convertible debentures (each a “Debenture”) at an issue price of C
The Debentures are issued pursuant to the terms of a debenture indenture dated September 4, 2024, between Company and Odyssey Trust Company, as debenture trustee and are unsecured obligations of the Company that mature September 4, 2028, and bear interest at a rate of
The Company may, at its option, force the conversion of the Debentures (the “Forced Conversion Right”) on ten (10) days’ notice if the volume weighted average trading price of the Common Shares on the TSXV is greater than C
Shane Madden, CEO and a director of the Company, commented, “As reflected in our Q2 financials, our company has now reached profitability, and we remain focused on growing the business with discipline and efficiency. This raise provides additional fuel to accelerate that growth and support our long-term strategy. We are very excited about the opportunities ahead in the remainder of 2025 and into 2026. I am deeply grateful to our investors, partners, clients, and our incredible team whose support and dedication have made these achievements possible."
In consideration for their services, the Agents received an aggregate
All securities issued in connection with the Offering – the Debentures, Debenture Shares, Broker Warrants, and Compensation Shares – are subject to a statutory hold period expiring four months and one day following the date of issuance, in accordance with applicable Canadian securities legislation.
The net proceeds of the Offering are expected to be used for general corporate and working capital purposes. The Offering remains subject to the final approval of the TSX Venture Exchange.
The securities described herein have not been, and will not be, registered under the U.S. Securities Act or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.
For further information, please contact:
Email: ir@hydreight.com
Phone: (480) 790 6886
About Hydreight Technologies Inc.
Hydreight Technologies Inc is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform hosts a network of over 2500 nurses, over 100 doctors, and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.
Cautionary Note Regarding Forward-Looking Statements
This news release contains statements that constitute “forward-looking statements.” Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or that events or conditions “will,” “would,” “may,” “could” or “should” occur.
Forward-looking statements in this news release include, among others, statements relating to expectations regarding the anticipated use of proceeds from the Offering, the terms of the Offering and the anticipated completion date, anticipated regulatory approvals and other statements that are not historical facts. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors and risks include, among others, the risk that the Offering will not be completed on the terms or timeline anticipated or at all; the Company may not obtain all required regulatory approvals for the Offering, including that of the TSX Venture Exchange; the Company may not be able to use the proceeds of the Offering as anticipated; the Company may require additional financing from time to time in order to continue its operations which may not be available when needed or on acceptable terms and conditions; compliance with extensive government regulation; domestic and foreign laws and regulations could adversely affect the Company’s business and results of operations; and the stock markets have experienced volatility that often has been unrelated to the performance of companies and these fluctuations may adversely affect the price of the Company’s securities, regardless of its operating performance.
The forward-looking information contained in this news release represents the expectations of the Company as of the date of this news release and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. The Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ
What is the size and terms of Hydreight's (HYDTF) convertible debenture offering?
When did Hydreight (HYDTF) become profitable?
What is the forced conversion trigger price for Hydreight's (HYDTF) convertible debentures?
How will Hydreight (HYDTF) use the proceeds from the convertible debenture offering?
What are the interest payment terms for Hydreight's (HYDTF) convertible debentures?
